Alloy Therapeutics Announces a Target Specific Collaboration and License Agreement for use of AntiClastic TM Antisense ...

US-based Normunity has raised $75m in a Series B funding round to support the clinical development of its lead programme, NRM-823, a potential first-in-class T-cell engager (TCE) targeting solid ...

It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...

Jefferies downgraded IGM Biosciences (IGMS) to Hold from Buy with a price target of $2, down from $48, after the company discontinued all clinical development of drugs in its autoimmune franchise ...

Nagpur: Saoner MLA Ashish Deshmukh has unveiled comprehensive plans for Saoner-Kalmeshwar area, encompassing an integrated fertiliser complex and a ferro alloy plant, aimed at fostering industrial ...

Identifying alloy properties can be expensive and time-consuming. Experiments involving alloys often require a number of resources. Calculating alloys can also become extremely complicated, with a ...

We are at a critical time and supporting climate journalism is more important than ever. Science News and our parent organization, the Society for Science, need your help to strengthen ...

Sanofi (NASDAQ:SNY) said that a Phase 3 study of its new subcutaneous formulation of Sarclisa in the treatment of multiple myeloma met its co-primary endpoints, demonstrating non-inferiority to ...

Alloy Therapeutics Inc. (Alloy), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, announced a target specific collaboration and license ...

[Read: Science is becoming less human] “The big turning point in the space was six years ago,” Ziv Bar-Joseph, a computational biologist at Carnegie Mellon University and the head of research and ...

A biotech ecosystem company seeking to democratize access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing ...